Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Bostik Implements Sopheon's Accolade System

18 Mar 2009 07:00

RNS Number : 0051P
Sopheon PLC
18 March 2009
 



Embargoed Release: 07:00hrs Wednesday 18 March 2009

Sopheon plc

('Sopheon')

Bostik Deploys Sopheon's Accolade® System to 

Enhance Product Innovation Results 

Software Solution Aids Product Development Decision-making and

Supports Revenue Growth from Increased Investment in Product Innovation

MINNEAPOLIS and LONDON─Mar.18, 2009─Sopheon, the international provider of software and services for product lifecycle management, announced today that Bostik SA, one of the world's leading manufacturers of adhesives and sealants, has implemented Sopheon's Accolade system to support advancement of the company's product innovation processes. The deployment provides access to the Sopheon software by cross-functional teams and business leaders responsible for product development and commercialisation throughout Bostik's worldwide operations. 

Bostik's history is a testimony to the business value of product innovation. Founded in 1889, the company began as a manufacturer of adhesives and polish for leather work and shoemaking. In the ensuing years, its product lines grew and became more diversified. For instance, a strategic focus on finding new applications for its chemical know-how led to the invention of hot-melt adhesives. The technology was used initially during World War II to hold parachute dummies together. Today, Bostik's adhesives are used for everything from sealing cereal boxes and gluing disposable diapers to bonding hulls to decks on leisure boats. The contribution of new products to Bostik's sales shows a pattern of consistent year-over-year increases. 

 

"Innovation is the engine that drives sustainable, profitable growth," said Bruno Charriere, corporate innovation director for Bostik. "We have stepped up our investment in product innovation with the objectives of growing faster and strengthening our competitive position through increased differentiation. With Sopheon's solution, we have end-to-end visibility and management across our product ideation, selection, development and commercialisation processes. The software gives us the consistent data we need for sound product innovation decisions. We view Accolade as a critical enabler of our efforts to ensure that we invest our resources in the right product opportunities, and bring those products to market at the right time."  

Bostik's choice of Accolade was based on such advantages as the solution's ease-of-use and simple configurability, and its strong alignment with the Stage-Gate® product development methodology that had already been introduced within the company. Executives benefit from comprehensive views of product portfolios that inform go/kill decisions about products in the pipeline and help to keep resources focused on the most commercially-promising projects. The system's reporting capabilities are used to make certain that project activity is aligned with financial and strategic business targets and linked to the company's operating plans. The software also facilitates shared learning and knowledge reuse among the company's cross-functional product development teams, helping them to avoid redundant work effort.

Bostik's implementation of Accolade includes the software's idea management and screening module, which facilitates the generation, capture and assessment of new product ideas. Bostik also intends to take advantage of Accolade's capacity to integrate with Microsoft® Office technology, a step that will give product development teams and executives the ability to access and share project-related information from enterprise-wide systems and use that data to make faster, better portfolio management decisions.

Sopheon partner and affiliate Sopheon France was responsible for the sale of Accolade to Bostik. It supported implementation of the software and subsequently maintains it. Patrice Duponchel, founding manager of Sopheon France, said, "As one of the top global manufacturers in France, Bostik is a skilled practitioner in the area of product innovation. And their business results have long shown it. A central thrust of Bostik's approach to product life cycle management is to find methods and tools that can add sophistication to their innovation processes by driving decisions that improve growth and profitability. Accolade is unsurpassed in its capacity to support the range of operational and business decision-making associated with product innovation. It is well-matched to the strategic goals of Bostik's continuing commitment to innovation-driven success."

 Accolade® and Vision Strategist™ are trademarks of Sopheon plc.

Stage-Gate® is a registered trademark of the Product Development Institute, Inc.

Microsoft® is a registered trademark of Microsoft Corporation.

All other trademarks are the sole property of their respective owners

-Ends-

For further information:

Barry Mence, Chairman

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Vikki Krause

Hansard Communications

+ 44 (0) 207 245 1100

+ 44 (0) 7957 203 685

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

Paul Davies, 

Corporate Finance

Seymour Pierce

+ 44 (0) 207 107 8000

About Bostik

Headquartered in Paris, France, Bostik SA is one of the top adhesives and sealants producers in the world. Its products are used in applications ranging from packaging, transportation, textiles and tapes, to diapers and insulating glass construction. The company has 5000 employees, 48 production facilities and sales operations in 39 countries across four continents. Bostik is owned by Total, one of the world's largest oil and gas companies. For more information, please visit www.bostik.com. 

About Sopheon

Sopheon (LSE:SPE) is an international provider of product lifecycle management software and services. Its solutions help organisations increase revenues and profits from new products by synchronising innovation planning and execution. Sopheon's Accolade® software automates the product innovation process and provides strategic decision support for the management of product portfolios. Its Vision Strategist™ solution automates the roadmapping process, allowing users to visualise and forecast the future of products, markets and technologies. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands.

For more information, please visit www.sopheon.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAILFEEVVIDLIA
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.